|
1
|
Gharavi NM, Alva JA, Mouillesseaux KP, Lai
C, Yeh M, Yeung W, Johnson J, Szeto WL, Hong L, Fishbein M, et al:
Role of the Jak/STAT pathway in the regulation of interleukin-8
transcription by oxidized phospholipids in vitro and in
atherosclerosis in vivo. J Biol Chem. 282:31460–31468. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Schober A, Nazari-Jahantigh M, Wei Y,
Bidzhekov K, Gremse F, Grommes J, Megens RT, Heyll K, Noels H,
Hristov M, et al: MicroRNA-126-5p promotes endothelial
proliferation and limits atherosclerosis by suppressing Dlk1. Nat
Med. 20:368–376. 2014. View
Article : Google Scholar : PubMed/NCBI
|
|
3
|
Gorenne I, Kumar S, Gray K, Figg N, Yu H,
Mercer J and Bennett M: Vascular smooth muscle cell sirtuin 1
protects against DNA damage and inhibits atherosclerosis.
Circulation. 127:386–396. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Zheng Y, Li Y, Liu G, Qi X and Cao X:
MicroRNA-24 inhibits the proliferation and migration of endothelial
cells in patients with atherosclerosis by targeting importin-α3 and
regulating inflammatory responses. Exp Ther Med. 15:338–344.
2018.PubMed/NCBI
|
|
5
|
Baumer Y, McCurdy S, Alcala M, Mehta N,
Lee BH, Ginsberg MH and Boisvert WA: CD98 regulates vascular smooth
muscle cell proliferation in atherosclerosis. Atherosclerosis.
256:105–114. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Luc G, Bard JM, Juhan-Vague I, Ferrieres
J, Evans A, Amouyel P, Arveiler D, Fruchart JC and Ducimetiere P;
PRIME Study Group, : C-reactive protein, interleukin-6, and
fibrinogen as predictors of coronary heart disease: The PRIME
study. Arterioscler Thromb Vasc Biol. 23:1255–1261. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Brunetti ND, Salvemini G, Cuculo A,
Ruggiero A, De Gennaro L, Gaglione A and Di Biase M: Coronary
artery ectasia is related to coronary slow flow and inflammatory
activation. Atherosclerosis. 233:636–640. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Zernecke A and Weber C: Chemokines in the
vascular inflammatory response of atherosclerosis. Cardiovasc Res.
86:192–201. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Barton M: Prevention and endothelial
therapy of coronary artery disease. Curr Opin Pharmacol.
13:226–241. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Holdt LM, Stahringer A, Sass K, Pichler G,
Kulak NA, Wilfert W, Kohlmaier A, Herbst A, Northoff BH, Nicolaou
A, et al: Circular non-coding RNA ANRIL modulates ribosomal RNA
maturation and atherosclerosis in humans. Nat Commun. 7:124292016.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Bayoumi AS, Aonuma T, Teoh JP, Tang YL and
Kim IM: Circular noncoding RNAs as potential therapies and
circulating biomarkers for cardiovascular diseases. Acta Pharmacol
Sin. 39:1100–1109. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Li CY, Ma L and Yu B: Circular RNA
hsa_circ_0003575 regulates oxLDL induced vascular endothelial cells
proliferation and angiogenesis. Biomed Pharmacother. 95:1514–1519.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Zheng C, Niu H, Li M, Zhang H, Yang Z,
Tian L, Wu Z, Li D and Chen X: Cyclic RNA has-circ-000595 regulates
apoptosis of aortic smooth muscle cells. Mol Med Rep. 12:6656–6662.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Diniz GP and Wang DZ: Regulation of
skeletal muscle by microRNAs. Compr Physiol. 6:1279–1294. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Lu C, Xie Z and Peng Q: MiRNA-107 enhances
chemosensitivity to paclitaxel by targeting antiapoptotic factor
Bcl-w in non small cell lung cancer. Am J Cancer Res. 7:1863–1873.
2017.PubMed/NCBI
|
|
16
|
Chen Z, Zhao L, Zhao F, Yang G and Wang J:
MicroRNA-26b regulates cancer proliferation migration and cell
cycle transition by suppressing TRAF5 in esophageal squamous cell
carcinoma. Am J Transl Res. 8:1957–1970. 2016.PubMed/NCBI
|
|
17
|
Undi RB, Kandi R and Gutti RK: MicroRNAs
as haematopoiesis regulators. Adv Hematol. 2013:6957542013.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Wang Y, Han Z, Fan Y, Zhang J, Chen K, Gao
L, Zeng H, Cao J and Wang C: MicroRNA-9 Inhibits NLRP3 inflammasome
activation in human atherosclerosis inflammation cell models
through the JAK1/STAT signaling pathway. Cell Physiol Biochem.
41:1555–1571. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Jiang ZP and Zhou TB: Role of miR-107 and
its signaling pathways in diseases. J Recept Signal Transduct Res.
34:338–341. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Liu F, Liu S, Ai F, Zhang D, Xiao Z, Nie X
and Fu Y: miR-107 promotes proliferation and inhibits apoptosis of
colon cancer cells by targeting prostate apoptosis response-4
(Par4). Oncol Res. 25:967–974. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Nelson PT and Wang WX: MiR-107 is reduced
in Alzheimer's disease brain neocortex: Validation study. J
Alzheimers Dis. 21:75–79. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Su SG, Yang M, Zhang MF, Peng QZ, Li MY,
Liu LP and Bao SY: miR-107-mediated decrease of HMGCS2 indicates
poor outcomes and promotes cell migration in hepatocellular
carcinoma. Int J Biochem Cell Biol. 91:53–59. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Foley NH and O'Neill LA: miR-107: A
Toll-like receptor-regulated miRNA dysregulated in obesity and type
II diabetes. J Leukoc Biol. 92:521–527. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Li F, Liu B, Gao Y, Liu Y, Xu Y, Tong W
and Zhang A: Upregulation of MicroRNA-107 induces proliferation in
human gastric cancer cells by targeting the transcription factor
FOXO1. FEBS Lett. 588:538–544. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Norata GD, Sala F, Catapano AL and
Fernandez-Hernando C: MicroRNAs and lipoproteins: A connection
beyond atherosclerosis? Atherosclerosis. 227:209–215. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Daimiel-Ruiz L, Klett-Mingo M,
Konstantinidou V, Micó V, Aranda JF, García B, Martínez-Botas J,
Dávalos A, Fernández-Hernando C and Ordovás JM: Dietary lipids
modulate the expression of miR-107, an miRNA that regulates the
circadian system. Mol Nutr Food Res. 59:552–565. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Hansen TB, Jensen TI, Clausen BH, Bramsen
JB, Finsen B, Damgaard CK and Kjems J: Natural RNA circles function
as efficient microRNA sponges. Nature. 495:384–388. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Kong X, Moran MS, Zhao Y and Yang Q:
Inhibition of metadherin sensitizes breast cancer cells to AZD6244.
Cancer Biol Ther. 13:43–49. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Tang CM, Zhang M, Huang L, Hu ZQ, Zhu JN,
Xiao Z, Zhang Z, Lin QX, Zheng XL, Yang M, et al: CircRNA_000203
enhances the expression of fibrosis-associated genes by
derepressing targets of miR-26b-5p, Col1a2 and CTGF, in cardiac
fibroblasts. Sci Rep. 7:403422017. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
O'Shea JJ and Plenge R: JAK and STAT
signaling molecules in immunoregulation and immune-mediated
disease. Immunity. 36:542–550. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Maschalidi S, Sepulveda FE, Garrigue A,
Fischer A and de Saint Basile G: Therapeutic effect of JAK1/2
blockade on the manifestations of hemophagocytic
lymphohistiocytosis in mice. Blood. 128:60–71. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Choi KB, Wong F, Harlan JM, Chaudhary PM,
Hood L and Karsan A: Lipopolysaccharide mediates endothelial
apoptosis by a FADD-dependent pathway. J Biol Chem.
273:20185–20188. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Jiang D, Yang Y and Li D:
Lipopolysaccharide induced vascular smooth muscle cells
proliferation: A new potential therapeutic target for proliferative
vascular diseases. Cell Prolif. 50:e123322017. View Article : Google Scholar
|
|
35
|
Liu M, Tao G, Liu Q, Liu K and Yang X:
MicroRNA let-7g alleviates atherosclerosis via the targeting of
LOX-1 in vitro and in vivo. Int J Mol Med. 40:57–64. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Burd CE, Jeck WR, Liu Y, Sanoff HK, Wang Z
and Sharpless NE: Expression of linear and novel circular forms of
an INK4/ARF-associated non-coding RNA correlates with
atherosclerosis risk. PLoS Genet. 6:e10012332010. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Wang R, Zhang Y, Xu L, Lin Y, Yang X, Bai
L, Chen Y, Zhao S, Fan J, Cheng X and Liu E: Protein inhibitor of
activated STAT3 suppresses oxidized LDL-induced cell responses
during atherosclerosis in apolipoprotein E-deficient mice. Sci Rep.
6:367902016. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Rane SG and Reddy EP: Janus kinases:
Components of multiple signaling pathways. Oncogene. 19:5662–5679.
2000. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Verma A, Kambhampati S, Parmar S and
Platanias LC: Jak family of kinases in cancer. Cancer Metastasis
Rev. 22:423–434. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Ortiz-Muñoz G, Martin-Ventura JL,
Hernandez-Vargas P, Mallavia B, Lopez-Parra V, Lopez-Franco O,
Muñoz-Garcia B, Fernandez-Vizarra P, Ortega L, Egido J and
Gomez-Guerrero C: Suppressors of cytokine signaling modulate
JAK/STAT-mediated cell responses during atherosclerosis.
Arterioscler Thromb Vasc Biol. 29:525–531. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Hiltunen MO, Tuomisto TT, Niemi M, Bräsen
JH, Rissanen TT, Törönen P, Vajanto I and Ylä-Herttuala S: Changes
in gene expression in atherosclerotic plaques analyzed using DNA
array. Atherosclerosis. 165:23–32. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Bennett MR, Evan GI and Newby AC:
Deregulated expression of the c-myc oncogene abolishes inhibition
of proliferation of rat vascular smooth muscle cells by serum
reduction, interferon-gamma, heparin, and cyclic nucleotide
analogues and induces apoptosis. Circ Res. 74:525–536. 1994.
View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Kutuk O and Basaga H: Bcl-2 protein
family: Implications in vascular apoptosis and atherosclerosis.
Apoptosis. 11:1661–1675. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Marin ML, Gordon RE, Veith FJ, Tulchin N
and Panetta TF: Distribution of c-myc oncoprotein in healthy and
atherosclerotic human carotid arteries. J Vasc Surg. 18:170–177.
1993. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Kockx MM, De Meyer GR, Muhring J, Jacob W,
Bult H and Herman AG: Apoptosis and related proteins in different
stages of human atherosclerotic plaques. Circulation. 97:2307–2315.
1998. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Saxena A, McMeekin JD and Thomson DJ:
Expression of Bcl-x, Bcl-2, Bax, and Bak in endarterectomy and
atherectomy specimens. J Pathol. 196:335–342. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Shi Y and Tokunaga O: Chlamydia pneumoniae
(C. pneumoniae) infection upregulates atherosclerosis-related gene
expression in human umbilical vein endothelial cells (HUVECs).
Atherosclerosis. 177:245–253. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Anikhovskaia IA, Kubatiev AA and Iakovlev
Mlu: Endotoxin theory of atherosclerosis. Fiziol Cheloveka.
41:106–116. 2015.(In Russian). PubMed/NCBI
|
|
49
|
Wort SJ and Evans TW: The role of the
endothelium in modulating vascular control in sepsis and related
conditions. Br Med Bull. 55:30–48. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Hennessy EJ, Sheedy FJ, Santamaria D,
Barbacid M and O'Neill LA: Toll-like receptor-4 (TLR4)
down-regulates microRNA-107, increasing macrophage adhesion via
cyclin-dependent kinase 6. J Biol Chem. 286:25531–25539. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Kumar V and Mahato RI: Delivery and
targeting of miRNAs for treating liver fibrosis. Pharm Res.
32:341–361. 2015. View Article : Google Scholar : PubMed/NCBI
|
